OnCo
technologiesTechnologyEstablished

Active surveillance of papillary microcarcinoma

Watching very small papillary thyroid cancers with ultrasound instead of operating, because most never grow and almost none cause harm.

Pioneered at Kuma Hospital (Japan) and Memorial Sloan Kettering: for papillary microcarcinomas (≤1 cm) without nodal or extrathyroidal disease, ~90% remain stable over a decade and delayed surgery is equally effective when needed. Endorsed by ATA guidelines; uptake outside Japan and Korea is still low. Addresses the overdiagnosis epidemic caused by ultrasound screening (South Korea's incidence rose 15-fold with no change in mortality).

Generic schematic · not to scale · placeholder for the surgery front
Patient-side cart · Wristed instrument arms · Target through 8 mm ports

How it works

Serial ultrasound at 6-12-month intervals with surgery triggered by growth ≥3 mm or nodal metastasis.

Strengths
  • Avoids lifelong thyroid hormone, voice and parathyroid injury for most
  • Cost-saving
Limitations
  • Patient anxiety; requires reliable follow-up
  • Not for tumours near the trachea or nerve

Latest papers

top
Literature trend0 papers in the last 12 monthsHow this is computed
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Active surveillance of papillary microcarcinoma" OR ABSTRACT:"Active surveillance of papillary microcarcinoma") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Active surveillance of papillary microcarcinoma, not a curated reading list.

Connected

9top